ALEXION PHARMA UK LIMITED
Get an alert when ALEXION PHARMA UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£15k
+503,733.3% vs 2024
Net assets
£9.3m
+66.9% vs 2024
Employees
73
-2.7% lowest in 3 filed years
Profit before tax
£5m
-21.6% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Confirmation statement overdue
Due 2026-10-31.
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £115,085,381 | £122,845,851 | £102,267,281 | -16.8% | |
| Operating profit | £5,576,279 | £5,886,077 | £4,854,791 | -17.5% | |
| Profit before tax | £6,458,282 | £6,369,682 | £4,993,717 | -21.6% | |
| Net profit | £4,814,854 | £4,656,096 | £3,746,184 | -19.5% | |
| Cash | £15,125 | £3 | £15,115 | +503,733.3% | |
| Total assets less current liabilities | £15,943,999 | £5,600,095 | £14,312,911 | +155.6% | |
| Net assets | £15,943,999 | £5,600,095 | £9,346,279 | +66.9% | |
| Equity | £15,943,999 | £5,600,095 | £9,346,279 | +66.9% | |
| Average employees | 81 | 75 | 73 | -2.7% | |
| Wages | £10,913,515 | £10,963,300 | £9,304,836 | -15.1% | |
| Directors' remuneration | £2,431,099 | £903,597 | £724,014 | -19.9% | |
| Highest paid director | £2,431,099 | £630,416 | £463,849 | -26.4% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 4.8% | 4.8% | 4.7% | |
| Net margin | 4.2% | 3.8% | 3.7% | |
| Return on capital employed | 35.0% | 105.1% | 33.9% | |
| Gearing (liabilities / total assets) | 72.7% | 83.2% | 74.8% | |
| Current ratio | 1.37x | 1.20x | 1.64x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- ALEXION PHARMA UK LIMITED 2006-11-03 → present
- PIMCO 2564 LIMITED 2006-10-17 → 2006-11-03
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After making enquiries, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future.”
Significant events
- “In Feb 2026, HMRC issued a provisional VAT assessment relating to the supply of free-of-charge (FOC) medicines and advised that the Company is liable for the associated deemed output VAT for the period 2022-2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 18 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OLLE, Francesc | Secretary | 2025-08-31 | — | — |
| ELLOIAN, Michael Ira Kenneth | Director | 2018-08-03 | May 1972 | American |
| OLLE, Francesc | Director | 2024-04-24 | Jun 1987 | Spanish |
| RICHARDS, Deborah | Director | 2024-04-24 | Sep 1967 | British |
Show 18 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BHALLA, Mayank, Dr | Secretary | 2024-04-24 | 2025-09-01 |
| DUFAUX, Philippe | Secretary | 2017-11-02 | 2024-02-02 |
| OLLE, Francesc | Secretary | 2024-02-02 | 2024-04-18 |
| PINSENT MASONS SECRETARIAL LIMITED | Corporate Secretary | 2006-10-17 | 2007-07-24 |
| YORK PLACE COMPANY SECRETARIES LIMITED | Corporate Secretary | 2007-06-01 | 2017-11-02 |
| BARRETT, Mark Shane | Director | 2007-06-01 | 2014-02-07 |
| COISSAC, Patrice | Director | 2006-11-16 | 2009-06-15 |
| DEVEQUE, Pierre | Director | 2007-09-01 | 2010-08-03 |
| DUBIN, Thomas I H | Director | 2009-06-15 | 2010-08-03 |
| FRAZER, Elaine | Director | 2016-12-06 | 2018-06-27 |
| FRYER, Jeffrey Michael | Director | 2009-06-15 | 2016-12-06 |
| GRECO, Michael Vincent | Director | 2010-08-03 | 2016-12-06 |
| GREER, Vivien Ruth | Director | 2018-08-03 | 2022-07-15 |
| KEISER, David Wharton | Director | 2007-09-01 | 2009-06-15 |
| RICHARDSON, Sean Barnaby Robert Knox | Director | 2018-04-17 | 2024-04-18 |
| TRAFFORD-JONES, Sara | Director | 2015-11-09 | 2018-04-17 |
| WOODS, Robert Keith | Director | 2014-02-07 | 2015-12-15 |
| PINSENT MASONS DIRECTOR LIMITED | Corporate Director | 2006-10-17 | 2006-11-16 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | Corporate entity | Shares 50–75%, Voting 50–75% | 2016-04-06 | Active |
Filing timeline
Last 20 of 108 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-10-08 | AA | accounts | Accounts with accounts type full | |
| 2025-11-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-07 | AA | accounts | Accounts with accounts type full | |
| 2025-09-10 | CH01 | officers | Change person director company with change date | |
| 2025-09-05 | CH01 | officers | Change person director company with change date | |
| 2025-09-05 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-09-05 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-10-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-11 | AA | accounts | Accounts with accounts type full | |
| 2024-04-24 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-04-24 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-24 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-23 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-23 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-02-19 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-02-02 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-02-02 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-10-30 | AA | accounts | Accounts with accounts type full | |
| 2023-10-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-03 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Spotted an error, or named here and want to reply? Report it · How we handle corrections